mdt
-
Spine
Medtronic Spine Sales Decline – Waiting For Infuse and Kyphoplasty
Walter Eisner • Thu, May 29th, 2014 Print this article Medtronic Inc.’s overall spine sales declined by 2% to $786…
Read More » -
Spine
Medtronic Q4 Reported Profit Drops 54% – Quick Facts
Medical device maker Medtronic, Inc. (MDT: Quote) announced a 54% fall in reported net earnings for the fourth quarter ended April…
Read More » -
Uncategorized
Medtronic exec: Google looms large as next great rival
May 7, 2014 by Brian Johnson Medtronic executive Dr. Stephen Oesterle thinks Google will be a force to be reckoned with in…
Read More » -
Biologics
Jury: Medtronic owes bone cement acquisition $15M
A jury awards $15 million to bone cement maker Pabban Development, ruling that Medtronic broke the terms of its deal…
Read More » -
Biologics
1,000 Infuse Patients File Lawsuits Against Medtronic
Infuse, Medtronic’s controversial bone growth product that has been the center of scientific and legal controversies, is the subject of…
Read More » -
Medtronic Reports Third Quarter Earnings
Revenue of $4.2 Billion Grew 4% on a Constant Currency Basis; 3% as Reported Non-GAAP Diluted EPS of $0.91; GAAP…
Read More » -
INFUSE Bone Graft Remains Important Treatment Option
MINNEAPOLIS – June 17, 2013 – Medtronic, Inc. [NYSE: MDT] acknowledged today the publication of the findings from Yale University’s third-party, independent review…
Read More » -
Medtronic Neuromodulation Business Gets FDA Warning Letter
Medtronic Inc.’s (MDT) business for neuromodulation devices recently received a Food and Drug Administration warning letter related mainly to the…
Read More » -
Medtronic Granted CE Mark
Medtronic has been rewarded with a CE Mark for a new non-surgical procedure it has devised that is suitable for…
Read More » -
Biologics
Medtronic receives notification that U.S. Department Of Justice and U.S. Attorney’s office have closed their investigation of activities relating to Infuse® bone graft
MINNEAPOLIS – MAY 16, 2012 – Medtronic, Inc. (NYSE: MDT) today announced it has been notified by the U.S. Department of Justice (DOJ) and the…
Read More » -
Med-tech trends: Styker, Medtronic, Covidien, St. Jude, Boston Scientific the most talked about device makers in April
MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last…
Read More » -
Medtronic to Ramp-Up Device Inspections
Medtronic, Inc., the world’s largest stand-alone medical device maker, is no longer going to rely on irregular reports from doctors…
Read More » -
Medtronic Announces Launch of the POWEREASE(TM) System
MEMPHIS, Tenn., Apr 16, 2012 (BUSINESS WIRE) — Medtronic, Inc. MDT -0.05% today announced the initiation of its launch of the POWEREASE(TM) System,…
Read More » -
More shareholders sue Medtronic over Infuse claims
Medtronic (NYSE:MDT) found itself at the center of another shareholder lawsuit accusing it of artificially boosting its stock price and…
Read More » -
Financial
Medical device tax to cost Medtronic about $125M to $175M annually
It appears that Medtronic (NYSE: MDT) is assuming that all the efforts to repeal the medical device taxare not going to amount to much…
Read More »